Sener AB, Seçkin NC, Ozmen S, Gökmen O, Doğu N, Ekici E. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Fertil Steril 1996;
65:354-7. [PMID:
8566261 DOI:
10.1016/s0015-0282(16)58098-4]
[Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
OBJECTIVE
To evaluate and compare the effects of two different modalities of hormone replacement therapy (HRT) on the size of uterine fibroids.
DESIGN
Randomized clinical study.
SETTING
The Menopause Center of a public hospital.
PATIENTS
Postmenopausal women with small asymptomatic uterine fibroids were selected.
INTERVENTIONS
One group was treated with 50 micrograms transdermal E2 plus 5 mg medroxyprogesterone acetate (MPA) continuously, whereas the second group was given 0.625 mg conjugated equine estrogen plus 2.5 mg MPA continuously.
MAIN OUTCOME MEASURE
The size of the uterine fibroids was measured before and after the first year of HRT.
RESULTS
At the end of the first year on HRT, the size of the uterine fibroids was re-evaluated sonographically and no significant difference was found with the oral group, whereas there was a significant increase in the transdermal group.
CONCLUSION
Hormone replacement therapy with 50 micrograms transdermal E2 plus 5 mg MPA increases the size of the uterine fibroids.
Collapse